Sun Pharma Q4 FY25 Results: PAT falls 19%, disappoints analysts; 550% dividend declared

Sun Pharma Q4 FY25 Earnings: Sun Pharma, a Mumbai-headquartered pharmaceutical giant, on Thursday reported a consolidated net profit of Rs 2,154 crore for the quarter ended March 31, missing analysts’ estimates. The quarterly net profit fell 19 per cent compared with the corresponding period a year ago, according to a regulatory filing.  The drug maker’s March-quarter…

Retail investors invested more than FPIs over past two decades: National Stock Exchange MD & CEO Ashish Kumar Chauhan

National Stock Exchange (NSE) Managing Director and CEO Ashish Kumar Chauhan on Thursday said retail investors in India — either directly or through Mutual Funds — have held more money than the Foreign Portfolio Investors (FPIs) over the past 20 years. Stock market investors’ base in India has grown leaps and bounds over the years…

GRSE jumped 11%, Cochin Shipyard, Solar Industries rally; Nifty Defence index jumps over 2% despite market crash; Know key reasons

Defence stocks bucked the broader market trend on May 22, closing deep in the green as geopolitical momentum, government thrust, and fresh orders triggered sharp rallies in key counters. The Nifty India Defence index surged 2.07 per cent to settle at 8,453.75, extending gains for a second straight session even as headline indices witnessed a…

‘ED crossing all limits, how can you…’: SC raps probe agency over TASMAC liquor case; DMK calls it ‘big blow’ to BJP’s narrative

The Supreme Court on Thursday stayed the Enforcement Directorate’s (ED) money laundering probe against Tamil Nadu’s state-run liquor retailer TASMAC over alleged irregularities in the grant of wine shop licences, drawing strong reactions from the ruling DMK in the state. Senior DMK leader and Rajya Sabha MP R S Bharathi welcomed the apex court’s order,…